Late ovarian relapse of TEL/AML1 positive ALL confirming that TEL deletion is a secondary event in leukemogenesis

Leukemia Research

Volumn 29, Issue 9, 2005, Pages 1089-1094

  Ly Sunnaram, Beatrice ^a   Henry, Catherine ^a   Gandemer, Virginie ^b   Le Mee, Franseza ^a   Burtin, Florence ^c   Blayau, Martine ^d   Cayuela, Jean Michel ^e   Oster, Magalie ^a   Clech, Philippe ^a   Rambeau, Marc ^f   Marie, Celine ^a   Pampin, Cecilia ^b   Edan, Christine ^b   Le Gall, Edouard ^b   Goasguen, Jean E ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

^c Laboratoire d'Anatomie Pathologique B   (France)

^d Lab de Génétique   (France)

^e Laboratoire Central d'Hematologie   (France)

^f RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

ALL; Ovarian tumor; Relapse; TEL; TEL AML1; Tetraploidy

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ASPARAGINASE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; PREDNISONE; TIOGUANINE; TRANSCRIPTION FACTOR RUNX1; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RELAPSE; CASE REPORT; CELL STRUCTURE; CHROMOSOME ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HUMAN; IMMUNOPHENOTYPING; LEUKEMOGENESIS; MOLECULAR BIOLOGY; MOLECULAR CLONING; OVARY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; CORE BINDING FACTOR ALPHA 2 SUBUNIT; FEMALE; GENE DELETION; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; ONCOGENE PROTEINS, FUSION; OVARIAN NEOPLASMS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 22144462147     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.11.027     Document Type: Article

References (26)

1. R. Fenrick, L. Wang, J. Nip, J.M. Amann, R.J. Rooney, and J. Walker-Daniels TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1 Mol Cell Biol 20 2000 5828 5839
2. L.V. Rompaey, M. Potter, C. Adams, and G. Grosveld TEL includes a G1 arrest and suppresses ras-induced transformation Oncogene 19 2000 5244 5250
3. T.W. McLean, S. Ringold, D. Neuberg, K. Stegmaier, R. Tantravahi, and J. Ritz TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia Blood 88 1996 4252 4258
4. R.G. Lopez, C. Carron, C. Oury, P. Gardellin, O. Bernard, and J. Ghysdael TEL is a sequence-specific transcriptional repressor J Biol Chem 274 1999 30132 30138
5. J.J.M. Van Dongen, E.A. Macintyre, J.A. Gabert, E. Delabesse, V. Rossi, and G. Saglio Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease Leukemia 13 1999 1901 1928
6. J. Gabert, E. Beillard, V.H.J. Van der Velden, W. Bi, D. Grimwade, and N. Pallisgaard Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia-A Europe against cancer program Leukemia 17 2003 2318 2357
7. A. Baruchel, J.M. Cayuela, E. Macintyre, R. Berger, and F. Sigaux Assesment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods: implication for a general strategy of minimal residual disease detection Br J Haematol 90 1995 85 93
8. J.W. Donovan, M. Ladetto, G. Zou, D. Neuberg, C. Poor, and D. Bowers Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia Blood 95 2000 2651 2658
9. T.R. Golub, G.F. Barker, S.K. Bohlander, S.W. Hiebert, D.C. Ward, and P. Bray-Ward Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia Proc Natl Acad Sci USA 92 1995 4917 4921
10. A. Zelent, M. Greaves, and T. Enver Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia Oncogene 23 2004 4275 4283
11. M.F. Greaves, A.T. Maia, J.L. Wiemels, and A.M. Ford Leukemia in twins: lessons in natural history Blood 102 2003 2321 2333
12. S. Raynaud, H. Cavé, M. Baens, C. Bastard, V. Cacheux, and J. Grosgeorge The 12;21 Translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia Blood 87 1996 2891 2899
13. S.P. Romana, M. Le Coniat, H. Poirel, P. Marynen, O.A. Bernard, and R. Berger Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21) Leukemia 10 1996 167 170
14. J.L. Wiemels, G. Cazzaniga, M. Daniotti, O.B. Eden, G.M. Addison, and G. Masera Prenatal origin of acute lymphoblastic leukaemia in children Lancet 354 1999 1499 1503
15. H. Mori, S.M. Colman, Z. Xiao, A.M. Ford, L.E. Healy, and C. Donaldson Chromosome translocations and covert leukemic clones are generated during normal fetal development Proc Natl Acad Sci USA 99 2002 8242 8247
16. A.T. Maia, A.M. Ford, G. Reza Jalali, C.J. Harrison, G. Malcom Taylor, and O.B. Eden Molecular tracking of leukemogenesis in a triplet pregnancy Blood 98 2001 478 482
17. A. Vora, L. Frost, A. Goodeve, G. Wilson, R.M. Ireland, and J. Lilleyman Late relapsing childhood lymphoblastic leukemia Blood 92 1998 2334 2337
18. A.M. Ford, K. Fasching, E.R. Pranzer-Grüyamer, M. Koenig, O.A. Haas, and M.F. Greaves Origins of "late" relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes Blood 98 2001 558 564
19. M. Konrad, M. Metzler, S. Panzer, I. Östreicher, M. Peham, and R. Repp Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone Blood 101 2003 3635 3640
20. S.D. Raynaud, N. Dastugue, D. Zoccola, S.A. Shurtleff, S. Mathew, and S.C. Raimondi Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia Leukemia 13 1999 1325 1330
21. D.J. Amor, E.M. Algar, H.R. Slater, and P.J. Smith High frequency of t(12;21) in childhood acute lymphoblastic leukemia detected by RT-PCR Pathology 30 1998 381 385
22. M.S. Jabbar Al-Obaidi, M. Martineau, C.F. Bennett, I.M. Franklin, A.H. Goldstone, and L. Harewood ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia Leukemia 16 2002 669 674
23. R. Codrington, H.E. O'Connor, G.R. Jalali, P. Carrara, M. Papaioannou, and S.M. Hart Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value Br J Haematol 111 2000 1071 1079
24. S.C. Raimondi, S.A. Shurtleff, S. Mathew, J.E. Rubnitz, M.L. Hancock, and G.K. Rivera Hyperdiploidy of more than 69 chromosomes is strongly associated with the TEL-AML1 fusion and favorable outcome for children with B lineage ALL Blood 94 Suppl. 1 1999 502a [Abstract]
25. R.C. Pais, T.H. Kim, G.T. Zwiren, and A.H. Ragab Ovarian tumors in relapsing acute lymphoblastic leukemia: a review of 23 cases J Pediatr Surg 26 1991 70 74
26. C.D. Chow, L. Dalla-Pozza, D.J. Gottlieb, and M.S. Hetzberg Two cases of very late relapsing childhood ALL carrying the TEL:AML1 fusion gene Leukemia 13 1999 1893 1894